Considerations When Treating Patients with Good-risk Germ Cell Tumors

Aditya Bagrodia, Costantine Albany, Clint Cary

Research output: Contribution to journalEditorialpeer-review

Abstract

Three cycles of bleomycin, etoposide, and cisplatin or four cycles of etoposide and cisplatin are options for patients with good-risk germ cell tumors. Despite no significant differences in clinical outcomes in a randomized trial, studies suggest variable impact on postchemotherapy retroperitoneal lymph node dissection histology, which may help inform treatment decisions.

Original languageEnglish (US)
Pages (from-to)1195-1198
Number of pages4
JournalEuropean Urology Focus
Volume6
Issue number6
DOIs
StatePublished - Nov 15 2020

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Considerations When Treating Patients with Good-risk Germ Cell Tumors'. Together they form a unique fingerprint.

Cite this